March 16, 2022
Article
Original Research
Kira MacDougall, MD, and co-investigators, research the importance of peripheral biomarkers in patients with advanced non–small cell lung cancer who are treated with pembrolizumab.
March 15, 2022
Article
Original Research
Shilong Wu, MD, and co-authors discuss how patients with thymoma are affected by prior cancer history.
March 14, 2022
Article
Case Study
Dr. Judd W. Moul, MD, and colleagues present the case of a man, aged 73 years, with a prostate-specific antigen level of 110 ng/mL after 4 negative prostate biopsies and 4 negative prostate MRIs.
March 12, 2022
Article
Interview
In an interview with ONCOLOGY®, Evan B. Bryson, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of amivantamab as therapy for patients with non–small cell lung cancer.
March 11, 2022
Article
Interview
“Team science is important for being open-minded [and] thinking outside of the box.”
March 10, 2022
Article
Editorial
In this month’s Letter to the Readers, ONCOLOGY co-editor-in-chief Howard S. Hochster, MD, reviews results of the CIRCULATE-Japan clinical trial that were presented at the 2022 Gastrointestinal Cancers Symposium.